TY - JOUR
T1 - Cardiac abnormalities assessed by non-invasive techniques in patients with newly diagnosed idiopathic inflammatory myopathies
AU - Diederichsen, Louise Pyndt
AU - Simonsen, Jane Angel
AU - Diederichsen, Axel Cosmus Pyndt
AU - Kim, Won Yong
AU - Hvidsten, Svend
AU - Hougaard, Mikkel
AU - Junker, Peter
AU - Lundberg, Ingrid E
AU - Petersen, Henrik
AU - Hansen, Esben Søvsø Szocska
AU - Eskerud, Karl Sannes
AU - Kay, Susan Due
AU - Jacobsen, Søren
PY - 2015/9/8
Y1 - 2015/9/8
N2 - Objective: Knowledge of cardiac involvement in idiopathic inflammatory myopathies (IIM) is limited, especially in the early stage of disease. The objective of the present study was to perform a controlled evaluation of cardiac abnormalities in newly diagnosed, untreated patients with idiopathic inflammatory myopathies (IIM) by means of non-invasive techniques. Methods: Fourteen patients with IIM (8 polymyositis, 4 dermatomyositis, 2 cancer-associated dermatomyositis) and 14 gender- and age- matched healthy control subjects were investigated. Participant assessments included a cardiac questionnaire, cardiac troponin-I (TnI), electrocardiogram (standard 12-lead and 48-h Holter monitoring), echocardiography with tissue Doppler measures, cardiac magnetic resonance (CMR) imaging with T2 mapping and semi-quantitative 99mtechnetium pyrophosphate (99mTc-PYP) scintigraphy. Results: Dyspnoea was present in 8 (57%) of the patients compared to none of the controls (p<0.01). Median levels of TnI in patients and controls were 20 ng/L and 6 ng/L, respectively (p=0.06). QTc intervals were prolonged in the patient group (p=0.01). Two patients had systolic dysfunction, and one diastolic dysfunction. The myocardial 99mTc-PYP uptake and CMR results differed between patients and controls, albeit not with statistical significance. Overall, cardiac abnormalities were demonstrated in 9 (64%) of the patients versus 2 (14%) of the controls (p=0.02). Conclusion: Cardiac abnormalities assessed by TnI, ECG or imaging modalities were significantly more common in newly diagnosed, treatment naïve patients with IIM compared to healthy control subjects. These abnormalities, although subclinical, may indicate that myocardial involvement is common in patients and calls for larger controlled studies and further investigations of the prognostic implications of this finding.
AB - Objective: Knowledge of cardiac involvement in idiopathic inflammatory myopathies (IIM) is limited, especially in the early stage of disease. The objective of the present study was to perform a controlled evaluation of cardiac abnormalities in newly diagnosed, untreated patients with idiopathic inflammatory myopathies (IIM) by means of non-invasive techniques. Methods: Fourteen patients with IIM (8 polymyositis, 4 dermatomyositis, 2 cancer-associated dermatomyositis) and 14 gender- and age- matched healthy control subjects were investigated. Participant assessments included a cardiac questionnaire, cardiac troponin-I (TnI), electrocardiogram (standard 12-lead and 48-h Holter monitoring), echocardiography with tissue Doppler measures, cardiac magnetic resonance (CMR) imaging with T2 mapping and semi-quantitative 99mtechnetium pyrophosphate (99mTc-PYP) scintigraphy. Results: Dyspnoea was present in 8 (57%) of the patients compared to none of the controls (p<0.01). Median levels of TnI in patients and controls were 20 ng/L and 6 ng/L, respectively (p=0.06). QTc intervals were prolonged in the patient group (p=0.01). Two patients had systolic dysfunction, and one diastolic dysfunction. The myocardial 99mTc-PYP uptake and CMR results differed between patients and controls, albeit not with statistical significance. Overall, cardiac abnormalities were demonstrated in 9 (64%) of the patients versus 2 (14%) of the controls (p=0.02). Conclusion: Cardiac abnormalities assessed by TnI, ECG or imaging modalities were significantly more common in newly diagnosed, treatment naïve patients with IIM compared to healthy control subjects. These abnormalities, although subclinical, may indicate that myocardial involvement is common in patients and calls for larger controlled studies and further investigations of the prognostic implications of this finding.
KW - Adult
KW - Aged
KW - Biomarkers
KW - Case-Control Studies
KW - Dermatomyositis
KW - Diagnostic Imaging
KW - Dyspnea
KW - Electrocardiography, Ambulatory
KW - Female
KW - Heart Diseases
KW - Humans
KW - Male
KW - Middle Aged
KW - Polymyositis
KW - Predictive Value of Tests
KW - Surveys and Questionnaires
KW - Troponin I
KW - Ventricular Dysfunction
KW - Ventricular Function
M3 - Journal article
C2 - 26343166
SN - 0392-856X
VL - 33
SP - 706
EP - 714
JO - Clinical and Experimental Rheumatology
JF - Clinical and Experimental Rheumatology
IS - 5
ER -